Addex Stock Analysis

ADXN Stock  USD 0.67  0.03  4.69%   
The big decline in price over the last few months for Addex Therapeutics could raise concerns from insiders as the firm is trading at a share price of 0.67 on 672,510 in volume. The company executives failed to add value to investors and position the firm supply of money to exploit market volatility in May. However, diversifying your holdings with Addex Therapeutics or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 8.13. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Addex Therapeutics partners.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide.
The main objective of Addex Therapeutics stock analysis is to determine its intrinsic value, which is an estimate of what Addex Therapeutics is worth, separate from its market price. There are two main types of Addex Therapeutics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Addex Therapeutics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Addex Therapeutics' stock to identify patterns and trends that may indicate its future price movements.
The Addex Therapeutics stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Addex Therapeutics is usually not traded on Christmas Day, Thanksgiving Day, Christmas Day ( substitute day ), New Year 's Monday, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Veterans Day ( substitute day ). Addex Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Addex Therapeutics' ongoing operational relationships across important fundamental and technical indicators.

Addex Stock Analysis Notes

About 18.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.41. Some equities with similar Price to Book (P/B) outperform the market in the long run. Addex Therapeutics recorded a loss per share of 2.52. The entity had not issued any dividends in recent years. Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system disorders in Switzerland. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland. Addex Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 26 people. For more info on Addex Therapeutics please contact Timothy Dyer at 41 22 884 1555 or go to

Addex Therapeutics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Addex Therapeutics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Addex Therapeutics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Addex Therapeutics generated a negative expected return over the last 90 days
Addex Therapeutics has high historical volatility and very poor performance
Addex Therapeutics has some characteristics of a very speculative penny stock
Addex Therapeutics has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 1.42 M. Net Loss for the year was (20.8 M) with profit before overhead, payroll, taxes, and interest of 1.44 M.
Addex Therapeutics currently holds about 8.81 M in cash with (16.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.4, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Addex Therapeutics has a frail financial position based on the latest SEC disclosures
Latest headline from Addex Receives Nasdaq Notification Regarding Minimum Bid Price ... - InvestorsObserver

Addex Therapeutics Upcoming and Recent Events

Earnings reports are used by Addex Therapeutics to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Addex Therapeutics previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
17th of August 2023
Upcoming Quarterly Report
30th of June 2023
Next Fiscal Quarter End

Addex Therapeutics SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Addex Therapeutics prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Addex Therapeutics investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Addex Therapeutics specific information freely available to individual and institutional make a timely investment decision.
1st of June 2023
Other Events
18th of May 2023
Other Events
11th of May 2023
Other Events
10th of May 2023
Other Events
5th of May 2023
Other Events
10th of April 2023
Unclassified Corporate Event
5th of April 2023
Unclassified Corporate Event
4th of April 2023
Other Events

Addex Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Addex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors.are aggressively trading Addex Therapeutics backward and forwards among themselves. Addex Therapeutics' institutional investor refers to the entity that pools money to purchase Addex Therapeutics' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Last TransactionTypeSharesValue
Nea Management Company Llc2023-03-31Common Shares5.6 M1.1 M
Armistice Capital Llc2022-09-30Common Shares320 K256 K
Endurant Capital Management Lp2023-03-31Common Shares120.7 K114.3 K
Old Mission Capital Llc 12023-03-31Common Shares65.7 K62.2 K
Virtu Financial Llc2023-03-31Common Shares42.9 K41 K
New Leaf Venture Partners Llc2022-09-30Common Shares50 K40 K
Citadel Advisors Llc2023-03-31Common Shares34.4 K32.5 K
Fny Investment Advisers Llc2022-09-30Common Shares22.5 K17 K
Millennium Management Llc2022-09-30Common Shares20 K16 K
Susquehanna International Group Llp2023-03-31Common Shares15.1 K14.3 K
Renaissance Technologies Llc2022-12-31Common Shares21.9 K14 K
Note, although Addex Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Addex Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Addex Therapeutics's market, we take the total number of its shares issued and multiply it by Addex Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Addex Profitablity

Addex Therapeutics' profitability indicators refer to fundamental financial ratios that showcase Addex Therapeutics' ability to generate income relative to its revenue or operating costs. If, let's say, Addex Therapeutics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Addex Therapeutics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Addex Therapeutics' profitability requires more research than a typical breakdown of Addex Therapeutics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2023
Return on Average Assets(1.68) (1.72) 
Return on Average Equity(2.55) (2.61) 
Return on Invested Capital 14.63  12.97 
Return on Sales(14.41) (14.79) 

Management Efficiency

Addex Therapeutics has return on total asset (ROA) of (0.8587) % which means that it has lost $0.8587 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.0424) %, meaning that it created substantial loss on money invested by shareholders. Addex Therapeutics' management efficiency ratios could be used to measure how well Addex Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of 6th of June 2023, Return on Average Assets is likely to drop to -1.72. In addition to that, Return on Average Equity is likely to drop to -2.61. Addex Therapeutics Tangible Asset Value is very stable at the moment as compared to the past year. Addex Therapeutics reported last year Tangible Asset Value of 8.28 Million
Last ReportedProjected for 2023
Book Value per Share 0.78  0.80 
Enterprise Value over EBIT(1.15) (1.24) 
Enterprise Value over EBITDA 0.28  0.31 
Price to Book Value 0.75  0.78 
Tangible Assets Book Value per Share 1.31  1.35 
Enterprise Value-6.1 M-6.3 M
Tangible Asset Value8.3 M8.5 M
The analysis of Addex Therapeutics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Addex Therapeutics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Addex Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Non Current Liabilities Total
87 K
Short Long Term Debt Total
373.1 K
Interest Expense
48.9 K
Total Operating Expenses
21.9 M

Technical Drivers

As of the 6th of June, Addex Therapeutics shows the mean deviation of 6.27, and Risk Adjusted Performance of (0.15). Addex Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Addex Therapeutics, which can be compared to its rivals. Please confirm Addex Therapeutics standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Addex Therapeutics is priced correctly, providing market reflects its regular price of 0.67 per share. As Addex Therapeutics is a penny stock we also strongly suggest to validate its total risk alpha numbers.

Addex Therapeutics Price Movement Analysis

The output start index for this execution was twenty-nine with a total number of output elements of thirty-two.

Addex Therapeutics Predictive Daily Indicators

Addex Therapeutics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Addex Therapeutics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Addex Therapeutics Forecast Models

Addex Therapeutics' time-series forecasting models are one of many Addex Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Addex Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Addex Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Addex Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Addex shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Addex Therapeutics. By using and applying Addex Stock analysis, traders can create a robust methodology for identifying Addex entry and exit points for their positions.
Last ReportedProjected for 2023
EBITDA Margin(14.18) (14.55) 
Gross Margin 0.90  0.89 
Profit Margin(14.63) (15.01) 

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Addex Therapeutics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Price Exposure Probability Now


Price Exposure Probability

Analyze equity upside and downside potential for a given time horizon across multiple markets
All  Next Launch Module
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Addex Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in commodities. To learn how to invest in Addex Stock, please use our How to Invest in Addex Therapeutics guide. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Complementary Tools for Addex Stock analysis

When running Addex Therapeutics' price analysis, check to measure Addex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Addex Therapeutics is operating at the current time. Most of Addex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Addex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Addex Therapeutics' price. Additionally, you may evaluate how the addition of Addex Therapeutics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Addex Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Addex Therapeutics. If investors know Addex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Addex Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Quarterly Revenue Growth
Return On Assets
Return On Equity
The market value of Addex Therapeutics is measured differently than its book value, which is the value of Addex that is recorded on the company's balance sheet. Investors also form their own opinion of Addex Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Addex Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Addex Therapeutics' market value can be influenced by many factors that don't directly affect Addex Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Addex Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Addex Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Addex Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.